At the news
? BEARISHIMPACT 5/10 6-K filed Jul 9, 2026 at 06:18 ET
Dr. Reddy's disclosed that certain batches of semaglutide (a key metabolic therapy) were found out of specification due to an API issue, delaying commercial supplies until the root cause is resolved. No patient safety impact or effect on existing regulatory filings, but the delay creates near-term revenue uncertainty for a high-demand product.
- Semaglutide batches out of specification due to API issue
- Commercial supplies delayed until root cause resolved
- No impact on patient safety or existing global regulatory filings
- Management conference call scheduled for July 9, 2026 at 16:30 IST
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access